PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Tytuł artykułu

Removal of clofibric acid and diclofenac during anaerobic digestion of sewage sludge

Treść / Zawartość
Identyfikatory
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
Removal of two acidic pharmaceuticals, clofibric acid and diclofenac, present in sewage sludge using two kinds of anaerobic digestions was investigated. The effective isolation and purification pretreatment to extract the target compounds from the sewage sludge samples was firstly established, followed by gas chromatography-mass spectrometry (GC-MS) analysis to identify and quantify them. Under mesophilic conditions, the removal efficiencies for clofibric acid and diclofenac with the initial concentrations of 5 μg /dm3 were up to 95% and 97%. After thermophilic anaerobic digestion, the removal efficiency could be increased to 99.3% for clofibric acid, however, it did not increase for diclofenac. In general, anaerobic digestion could effectively remove the target compounds from the sewage sludge (all above 90%).
Rocznik
Strony
63--77
Opis fizyczny
Bibliograf. 25 poz., tab., rys.
Twórcy
autor
  • School of Environment and Architecture, University of Shanghai for Science and Technology, Shanghai, China
autor
  • School of Environment and Architecture, University of Shanghai for Science and Technology, Shanghai, China
autor
  • School of Environment and Architecture, University of Shanghai for Science and Technology, Shanghai, China
autor
  • School of Optical-Electrical and Computer Engineering, University of Shanghai for Science and Technology, Shanghai, China
autor
  • School of Environmental and Safety Engineering, Changzhou University, Changzhou, China
autor
  • College of Environmental Science and Engineering, South China University of Technology, Guangzhou, China.
autor
  • School of Environment and Architecture, University of Shanghai for Science and Technology, Shanghai, China
Bibliografia
  • [1] HEBERER T., Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data, Toxicol. Lett., 2002, 131 (1–2), 5.
  • [2] CASTIGLIONI S., BAGNATI R., FANELLI R., POMATI F., CALAMARI D., ZUCCATO E., Removal of pharmaceuticals in sewage treatment plants in Italy, Environ. Sci. Technol., 2006, 40 (1), 357.
  • [3] TAUXE-WUERSCH A., DE ALENCASTRO L.F., GRANDJEAN D., TARRADELLAS J., Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment, Water Res., 2005, 39 (9), 1761.
  • [4] MIAO X.S., YANG J.J., METCALFE C.D., Carbamazepine and its metabolites in wastewater and in biosolids in a municipal wastewater treatment plant, Environ. Sci. Technol., 2005, 39 (19), 7469.
  • [5] BEHERA S.K., KIM H.W., OH J.E., PARK H.S., Occurrence and removal of antibiotics, hormones and several other pharmaceuticals in wastewater treatment plants of the largest industrial city of Korea, Sci. Total Environ., 2011, 409 (20), 4351.
  • [6] ROCCO L., PELUSO C., VALENTINO I.V., STINGO V., Computational biology for risk assessment of PPCPs released in the aquatic environment, Toxicol. Lett., 2011, 205, 97.
  • [7] BUSER H.R., POIGER T., MULLER M.D., Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater, Environ. Sci. Technol., 1999, 33 (15), 2529.
  • [8] ZHANG Y., GEISSEN S.U., GAL C., Carbamazepine and diclofenac. Removal in wastewater treatment plants and occurrence in water bodies, Chemosphere, 2008, 73 (8), 1151.
  • [9] ZHOU H., HUANG X., WEN X., Progress of the studies on occurrence and fate of new emerging micropollutants PPCPs in municipal wastewaters, Chinese J. Environ. Eng., 2007, 1 (12), 1 (in Chinese).
  • [10] XUE W., WU C., XIAO K., HUANG X., ZHOU H., TSUNO H., TANAKA H., Elimination and fate of selected micro-organic pollutants in a full-scale anaerobic/anoxic/aerobic process combined with membrane bioreactor for municipal wastewater reclamation, Water Res., 2010, 44 (20), 5999.
  • [11] SNYDER S.A., Occurrence of pharmaceuticals in US drinking water, [in:] R.U. Halden (Ed.), Contaminants of Emerging Concern in the Environment: Ecological and Human Health Considerations, 2010, 1048, 69–80.
  • [12] DAUGHTON C.G., Pharmaceutical ingredients in drinking water. Overview of occurrence and significance of human exposure, [in:] R.U. Halden (Ed.), Contaminants of Emerging Concern in the Environment: Ecological and Human Health Considerations, 2010, 1048, 9–68.
  • [13] SCHEURELL M., FRANKE S., SHAH R.M., HÜHNERFUSS H., Occurrence of diclofenac and its metabolites in surface water and effluent samples from Karachi, Pakistan, Chemosphere, 2009, 77 (6), 870.
  • [14] ZHAO J.L., YING G.G., WANG L., YANG J.F., YANG X.B., YANG L.-H., LI X., Determination of phenolic endocrine disrupting chemicals and acidic pharmaceuticals in surface water of the Pearl Rivers in South China by gas chromatography-negative chemical ionization-mass spectrometry, Sci. Total Environ., 2009, 407 (2), 962.
  • [15] LEE J., JI K., KHO Y.L., KIM P., CHOI K., Chronic exposure to diclofenac on two freshwater cladocerans and Japanese medaka, Ecotoxicol. Environ. Saf., 2011, 74 (5), 1216.
  • [16] SARAVANAN M., KARTHIKA S., MALARVIZHI A., RAMESH M., Ecotoxicological impacts of clofibric acid and diclofenac in common carp (Cyprinus carpio) fingerlings.: Hematological, biochemical, ionoregulatory and enzymological responses, J. Hazard. Mater., 2011, 195, 188.
  • [17] FERRARI B.T., PAXÉUS N., GIUDICE R.L., POLLIO A., GARRIC J., Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac, Ecotoxicol. Environ. Saf., 2003, 55 (3), 359.
  • [18] NASSEF M., MATSUMOTO S., SEKI M., KHALIL F., KANG I.J., SHIMASAKI Y., OSHIMA Y., HONJO T., Acute effects of triclosan, diclofenac and carbamazepine on feeding performance of Japanese medaka fish (Oryzias latipes), Chemosphere, 2010, 80 (9), 1095.
  • [19] LEE J., JI K., LIM KHO Y., KIM P., CHOI K., Chronic exposure to diclofenac on two freshwater cladocerans and Japanese medaka, Ecotoxicol. Environ. Saf., 2011, 74 (5), 1216.
  • [20] TRIEBSKORN R., CASPER H., HEYD A., EIKEMPER R., KÖHLER H.R., SCHWAIGER J., Toxic effects of the non-steroidal anti-inflammatory drug diclofenac, Aquat. Toxicol., 2004, 68 (2), 151.
  • [21] HOSPIDO A., CARBALLA M., MOREIRA M., OMIL F., LEMA J.M., FEIJOO G., Environmental assessment of anaerobically digested sludge reuse in agriculture: Potential impacts of emerging micropollutants, Water Res., 2010, 44 (10), 3225.
  • [22] CARBALLA M., OMIL F., TERNES T., LEMA J.M., Fate of pharmaceutical and personal care products (PPCPs) during anaerobic digestion of sewage sludge, Water Res., 2007, 41 (10), 2139.
  • [23] AYSCOUGH N.J., FAWELL J., FRANKLIN G., YOUNG W., R & D Technical Report P390, UK Environmental Agency, Bristol, 2000,
  • [24] ZHOU H., ZHOU Y., LI H., WANG F., Fate and removal of selected endocrine-disrupting compounds in sewage using activated sludge treatment, Water Environ. J., 2012, 26, 435.
  • [25] COELHO A.D., SANS C., AGÜERA A., GÓMEZ M.J., ESPLUGAS S., DEZOTTI M., Effects of ozone pretreatment on diclofenac: Intermediates, biodegradability and toxicity assessment, Sci. Total Environ., 2009, 407, 3572.
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-5d94d922-85fb-4cca-a598-92669835e1c2
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.